Natasha Leskovsek

Of Counsel
Full contact info

I’ve taken my clinical and consulting experience for pharma and biotech companies on regulatory issues and brought them to Cooley’s clients.

Passions

Providing practical compliance solutions at the intersection of science and regulation

Experience

Upstream Bio Announces Upsized $293 Million IPO

October 15, 2024

Cooley advised the underwriters of Upstream Bio, a clinical-stage biotech developing a monoclonal antibody to target respiratory disorders, on its upsized $293 million initial public offering.

Read more

Related contacts

Kristin VanderPas
Partner, San Francisco
David Peinsipp
Partner, San Francisco
Denny Won
Partner, San Francisco
Charlie Kim
Partner, San Diego
Claire Keast-Butler
Co-Partner in Charge – London, London
Xander Lee
Partner, Santa Monica
Barbara Mirza
Partner, Santa Monica
Phil Mitchell
Partner, New York
Madhuri Roy
Partner, Palo Alto
Francis Wheeler
Partner, Colorado
Rebecca Ross
Special Counsel, Washington, DC
Randy Sabett
Special Counsel, Washington, DC
Natasha Leskovsek
Of Counsel, Washington, DC
Elizabeth Caruso
Associate, New York
Mandy Ching
Associate, London
Megan Drill
Associate, San Diego
Zack Gong
Associate, Shanghai
Peter A. Haddad
Associate, San Diego
David D. Kim
Associate, San Francisco
Jessica Koffel
Associate, Brussels
Sarah Miller
Associate, New York
Lawrence Traylor
Associate, Santa Monica

Related Practices & Industries

BioAge Labs Announces $198 Million IPO

September 27, 2024

Cooley advised the underwriters of BioAge Labs, a clinical-stage biotechnology company that is harnessing the biology of human aging to develop novel targets and therapies for metabolic diseases, on its $198 million initial public offering.

Read more

Related contacts

Charlie Kim
Partner, San Diego
Denny Won
Partner, San Francisco
Div Gupta
Partner, New York
Jon Cousin
Partner, Washington, DC
Lila Hope
Partner, Palo Alto
Xander Lee
Partner, Santa Monica
Joshua Mates
Partner, San Francisco
Phil Mitchell
Partner, New York
Alessandra Murata
Partner, Palo Alto
David Peinsipp
Partner, San Francisco
Madhuri Roy
Partner, Palo Alto
Francis Wheeler
Partner, Colorado
Randy Sabett
Special Counsel, Washington, DC
Karen Tsai
Special Counsel, Washington, DC
Natasha Leskovsek
Of Counsel, Washington, DC
Elizabeth Caruso
Associate, New York
Tony P. Guan
Associate, Santa Monica
Tony P. Guan
Associate, Santa Monica
Jonathan Kaufman
Associate, Palo Alto
Wyatt Kernell
Associate, Colorado
Ryan Lewis
Associate, Colorado
Sarah Miller
Associate, New York
Eric Owens
Associate, New York
Breanna Qin
Associate, Palo Alto
Dr. Xixi Sun
Associate, Boston
Christine Turner
Associate, Colorado
Mark Westwood
Associate, Palo Alto
Joanna Zhang
Associate, San Diego
Daniel Manson
Patent Agent, New York
Robin K. Lee
Paralegal Specialist, Colorado

Related Practices & Industries

Zenas BioPharma Announces $225 Million IPO

September 16, 2024

Cooley advised Morgan Stanley, Jefferies, Citigroup and Guggenheim Securities as the underwriters of Zenas BioPharma’s $225 million initial public offering.

Read more

Related contacts

Richard Segal
Partner, New York
Denny Won
Partner, San Francisco
Div Gupta
Partner, New York
Evan Leitner
Associate, New York
Barbara Mirza
Partner, Santa Monica
Phil Mitchell
Partner, New York
Stephanie Gentile
Partner, New York
Austin Holt
Partner, Santa Monica
David Peinsipp
Partner, San Francisco
Madhuri Roy
Partner, Palo Alto
Geoffrey Spolyar
Partner, Boston
Francis Wheeler
Partner, Colorado
Rebecca Ross
Special Counsel, Washington, DC
Randy Sabett
Special Counsel, Washington, DC
Natasha Leskovsek
Of Counsel, Washington, DC
Nathaniel Hearn Jr.
Associate, Chicago
Wyatt Kernell
Associate, Colorado
Allison Kutner
Associate, New York
Aaron Level
Associate, New York
Brenna McGuire
Associate, New York
Amanda Pacheco
Associate, Palo Alto
Jesse Schulman
Associate, Colorado
Nitasha Bennett
Patent Agent, San Diego
Jeffery Wyzykowski
Patent Agent, Washington, DC

Related Practices & Industries

Ionis – $500.3 Million Public Offering of Common Stock

September 11, 2024

Cooley advised Ionis Pharmaceuticals (Nasdaq: IONS), a biotechnology research company inventing medicines that bring better futures to people with serious diseases, on its $500.3 million underwritten public offering of common stock.

Read more

Related contacts

Charlie Kim
Partner, San Diego
Natalie Karam
Partner, Palo Alto
Nicholaus E. Johnson
Associate, San Diego
Jayden Martinez
Associate, Colorado
Allie Pilmer
Associate, San Diego
Jon Cousin
Partner, Washington, DC
Todd Gluth
Partner, San Diego
Phil Mitchell
Partner, New York
David Navetta
Partner, Colorado
Jason Savich
Partner, San Francisco
Alan W. Tamarelli
Partner, New York
Thomas Welk
Senior Counsel, San Diego
Francis Wheeler
Partner, Colorado
Mark Windfeld-Hansen
Senior Counsel, Palo Alto
Karen Tsai
Special Counsel, Washington, DC
Natasha Leskovsek
Of Counsel, Washington, DC
David Dalton
Associate, Santa Monica
Erin Hilliard
Associate, San Francisco
Jesse Schulman
Associate, Colorado

Related Practices & Industries

Cooley Advises on Candid Therapeutics’ $370 Million Capital Raise, Three-Way Merger

September 9, 2024

Cooley advised Candid Therapeutics, a biotechnology company dedicated to developing potentially transformative drugs to address autoimmune diseases, on its $370 million debut capital raise and three-way merger with Vignette Bio and TRC 2004.

Read more

Related contacts

Carlos Ramirez
Partner, San Diego
Edmond Lay
Associate, San Diego
Matthew D. Silverman
Special Counsel, Santa Monica
Ben Beerle
Partner, San Francisco
Leina Verrier
Associate, Santa Monica
Jayden Martinez
Associate, Colorado
Jack Whitaker
Associate, San Diego
Dillon Martinson
Special Counsel, Washington, DC
Stephanie Gentile
Partner, New York
Calvin Lee
Associate, New York
Megan Browdie
Partner, Washington, DC
Nicholas Orr
Associate, Los Angeles
Sharon Connaughton
Special Counsel, Washington, DC
Patricia Myers
Paralegal Specialist, Colorado
Linh Nguyen
Associate, San Diego
Mark Windfeld-Hansen
Senior Counsel, Palo Alto
Kate Walther
Paralegal Specialist, San Diego
John Sellers
Partner, Palo Alto
Katie Kissner
Quantitative Analyst, San Francisco
Natasha Leskovsek
Of Counsel, Washington, DC

Related Practices & Industries

View more

Admissions and credentials

District of Columbia

Maryland

Memberships and affiliations

Food and Drug Law Institute